Evaluating the Effect of CHanging EnfuvirtidE to Raltegravir in HIV Infected Subjects

NCT00529243 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

52

Enrollment

OTHER

Sponsor class

Conditions

HIV Infections

Interventions

DRUG: raltegravir

Sponsor

Kaiser Permanente

Collaborators

[object Object]